AHA urges FDA to quickly resolve shortages of certain critical drug products

AHA urges the Food and Drug Administration (FDA) to take any and all steps possible to expedite the resolution of the worsening shortages of small-volume parenteral solutions that are so fundamental to patient care in hospitals.

Related Resources

AHA Center for Health Innovation Market Scan
Fund managers now target companies addressing health equity with solutions aimed at increasing access and improving outcomes for historically underserved and…
Advancing Health Podcast
Community investment, otherwise known as place-based investment, helps create the social and physical environments that support community health over the long…
Letter/Comment
Public
AHA’s Response to Senate Finance Committee’s Request for Information on Behavioral Health Care In the U.S.
Frequently Asked Questions (FAQs)
AHA is seeking health systems to help identify and address IPC training needs.
Advancing Health Podcast
Community Investment Series Community investment, otherwise known as place-based investment, helps create the social and physical environments that support…
Advancing Health Podcast
Community Investment Series Community investment, otherwise known as place-based investment, helps create the social and physical environments that support…